Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Virogenomics BioDevelopment Inc in April, 2019 for $299,560.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41DA047865-01A1 | Phase I | 299,560 | April 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Virogenomics BioDevelopment Inc in April, 2020 for $998,210.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI122574-04A1 | Phase II | 998,210 | April 17, 2020 | |||||||
A SBIR Phase I contract was awarded to Virogenomics BioDevelopment Inc in September, 2019 for $268,643.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL147757-01 | Phase I | 268,643 | September 28, 2019 | |||||||
A STTR Phase I contract was awarded to Virogenomics BioDevelopment Inc in July, 2015 for $224,886.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41DA039632-01 | Phase I | 224,886 | July 1, 2015 | |||||||
A STTR Phase I contract was awarded to Virogenomics BioDevelopment Inc in February, 2016 for $224,796.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI122574-01 | Phase I | 224,796 | February 1, 2016 | |||||||
A STTR Phase I contract was awarded to Virogenomics BioDevelopment Inc in August, 2017 for $299,186.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41NS103644-01 | Phase I | 299,186 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Virogenomics BioDevelopment Inc in September, 2016 for $299,931.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA203681-01A1 | Phase I | 299,931 | September 21, 2016 | |||||||
A STTR Phase II contract was awarded to Virogenomics BioDevelopment Inc in July, 2017 for $1,450,053.0 USD from the U.S. Department of Health & Human Services. | STTR | 2R42AI122574-02 | Phase II | 1,450,053 | July 17, 2017 |